Buprenorphine Hcl And Naloxone Hcl 65162-0415
Generic: Buprenorphine And Naloxone
Product NDC
65162-0415- Manufacturer
- Amneal Pharmaceuticals Llc
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- February 22, 2013
- Listing Expires
- December 31, 2027
- Application
- ANDA203136
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride Dihydrate | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(2)
30 TABLET in 1 BOTTLE (65162-415-03)
90 TABLET in 1 BOTTLE (65162-415-09)